These genes were RAD50, PALB2, FANCD2, FANCI, SLX4 and RAD51C. They accounted for 31.6% (6/19) of all of the non-BRCA mutation genes, which confirmed that multiple genes in the FA pathway are associated with breast cancer risk [21]. This evidence concerns the gene RAD51C and breast cancer.